Biotech Values

[IanFromSI]

I believe getting a blood sample is usually a lot less invasive than a tumour biopsy; that sensitivity to the DNA fragment or mRNA or whatever will make this the diagnostic tool of choice.

However, you're probably right that it will be a very long time before the blood test approach becomes an effective, all inclusive means of detecting all types of cancer and the most appropriate tx.

From what I've seen so far, FMI isn't at risk from these companies any time soon. That could change without much notice however.